| Patents for A61P 5 - Drugs for disorders of the endocrine system (28,908) |
|---|
| 02/24/2009 | US7494661 Methods for using tetanus toxin for beneficial purposes in animals (mammals) |
| 02/24/2009 | CA2432085C Indole derivatives and their use as 5-ht2b and 5-ht2c receptor ligands |
| 02/19/2009 | WO2009023181A1 6-SUBSTITUTED SULFONYL AZABICYCLO[3.2.1]OCTANES USEFUL TO INHIBIT 11β-HYDROXYSTEROID DEHYDROGENASE TYPE-1 |
| 02/19/2009 | WO2009023180A1 SUBSTITUTED BICYCLIC PIPERIDINYL-AND PIPERAZINYL- SULFONAMIDES USEFUL TO INHIBIT 11β-HYDROXYSTEROID DEHYDROGENASE TYPE-1 |
| 02/19/2009 | WO2009021323A1 Dhea compositions for treating menopause |
| 02/19/2009 | WO2008100560A3 Estrogen receptor modulators, associated pharmaceutical compositions and methods of use |
| 02/19/2009 | US20090048226 Inhibitors of caspases |
| 02/19/2009 | US20090048217 17Beta-CYANO-19-NOR-ANDROST-4-ENE DERIVATIVE, ITS USE AND MEDICAMENTS COMPRISING THE DERIVATIVE |
| 02/19/2009 | US20090048185 Therapeutic Drug for Suppressing Functions of NKT Cells Containing Glycolipid Derivative as Active Ingredient |
| 02/19/2009 | US20090048184 Method for Producing a Drug Extract That Contains Hydroxystilbene |
| 02/19/2009 | US20090047687 Indane Acetic Acid Derivatives and Their Use as Pharmaceutical Agents, Intermediates, and Method of Preparation |
| 02/19/2009 | CA2696288A1 6-substituted sulfonyl azabicyclo[3.2.1]octanes useful to inhibit 11.beta.-hydroxysteroid dehydrogenase type-1 |
| 02/19/2009 | CA2696285A1 Substituted bicyclic piperidinyl- and piperazinyl-sulfonamides useful to inhibit 11.beta.-hydroxysteroid dehydrogenase type-1 |
| 02/19/2009 | CA2696127A1 Dhea compositions for treating menopause |
| 02/18/2009 | EP2024383A2 Crystalline forms of 11 beta-(4-acetylphenyl)-20,20,21,21,21-pentafluor-17alpha- hydroxy-19-nor-17 -pregna-4,9-dien-3-one |
| 02/18/2009 | EP2024336A1 Novel pharmaceutical compositions |
| 02/18/2009 | EP1569635B1 Use of carnitines for the prevention and/or treatment of disorders caused by the andropause |
| 02/18/2009 | EP1513493B1 Analgesics |
| 02/18/2009 | EP1360178B1 Novel heterocyclic analogs of diphenylethylene compounds |
| 02/18/2009 | CN101366847A Medicament for treating atrophic thyroiditis |
| 02/18/2009 | CN100462359C 5-sulfanyl-4H-1,2,4-triazole derivatives and their use as a medicament |
| 02/18/2009 | CN100462353C Propionamide derivatives used as androgen receptor modulators |
| 02/18/2009 | CN100462351C Amino acids with affinity for the alpha-2-delta-protein |
| 02/18/2009 | CN100462078C Compound estradiol valerate tablet and its preparation process |
| 02/18/2009 | CN100462073C Compositions useful for the treatment of pathologies responding to the activation of PPAR-gamma receptor |
| 02/17/2009 | US7491550 Diagnostics and therapeutics for diseases associated with Neuromedin U2 receptor (NMU2) |
| 02/12/2009 | WO2009020234A2 Pyrrolidin-2 -one derivatives as androgen receptor modulator |
| 02/12/2009 | US20090042857 Novel Pharmaceutical |
| 02/12/2009 | US20090042818 Liquiritigenin and Derivatives as Selective Estrogen Receptor Beta Agonists |
| 02/12/2009 | US20090042778 Methods for Suppressing Neovascularization Using Ephrinb2 |
| 02/12/2009 | US20090042199 Nucleotide sequences coding lymphocyte adhesion protein for use in treatment of autoimmunity, inflammation and infection |
| 02/12/2009 | US20090041731 Treatment for Diabetes |
| 02/12/2009 | CA2695852A1 Cyclic amine compounds |
| 02/12/2009 | CA2691445A1 Enzymatic process for obtaining 17 alpha-monoesters of cortexolone and/or its 9,11-dehydroderivatives |
| 02/11/2009 | EP2022796A1 Amorphous ciclesonide |
| 02/11/2009 | EP2021368A1 Derivatized insulin oligomers |
| 02/11/2009 | EP2021320A2 2-substituted-1alpha, 25-dihydroxy-19,26,27-trinor vitamin d analogs and uses thereof |
| 02/11/2009 | EP1581307A4 Irs modulators |
| 02/11/2009 | CN101365476A Combined use of dpp iv inhibitors and gastrin compounds |
| 02/11/2009 | CN101361953A Use of Sini decoction in preparing medicine for treating hypothyroidism sexual function reduction |
| 02/11/2009 | CN101361535A Compound pollen cream and preparation method thereof |
| 02/11/2009 | CN100460414C Stable vitamin B6 derivative |
| 02/10/2009 | US7488829 Diphenylazetidinones, process for their preparation, medicaments comprising these compounds and their use |
| 02/10/2009 | US7488734 Anticancer agents; hormone replacement therapy; contraceptives |
| 02/10/2009 | US7488494 Competitive binding to estrogen; prevent mnopause syndrome ; anxiolytic agents; antidepressants; benign prostatic hyperplasia; anticancer agents; inflammatory bowel disorders; antiarthritic agents |
| 02/10/2009 | CA2383659C Mesoprogestins (progesterone receptor modulators) as a component of compositions for hormone replacement therapy (hrt) |
| 02/10/2009 | CA2294098C Novel thyroid receptor ligands and method |
| 02/05/2009 | WO2009016253A2 Cyanomethyl substituted n-acyl tryptamines |
| 02/05/2009 | US20090036491 Transdermal pharmaceutical delivery compositions |
| 02/05/2009 | US20090036442 N-aroyl cyclic amine derivatives as orexin receptor antagonists |
| 02/04/2009 | EP2020404A1 Cyanomethyl substituted N-Acyl Tryptamines |
| 02/04/2009 | EP2020236A1 Contraceptive medicament based on a progestative and oestrogen, method for producing the same, and use |
| 02/04/2009 | EP1542976B1 Substituted 4-(indazol-3-yl)phenols as estrogen receptor (er) ligands and their use in the treatment of inflammatory diseases |
| 02/04/2009 | CN100457777C Leucine-based motif and clostridial neurotoxins |
| 02/04/2009 | CN100457088C Pharmaceutical composition comprising lipids comprising polar and nonpolar moiety parts |
| 02/04/2009 | CN100456950C Use of iodine for preparing diet preventing hyperthyroidism of cat |
| 02/03/2009 | US7485713 Polypeptides comprising growth hormone receptor extracellular domain and glycosylphosphatidylinositol |
| 02/03/2009 | US7485660 For selectively modulating the activation, repression, agonism and antagonism effects of the glucocorticoid receptor in a patient; for therapy and prophylaxis of obesity, diabetes, depression, neurodegeneration or an inflammatory disease |
| 02/03/2009 | US7485647 2-aminoquinoline derivatives |
| 02/03/2009 | US7485645 prostate cancer, benign prostatic hyperplasia, acne, seborrhea, hirsutism, androgenic alopecia, precocious puberty, adrenal hyperlasia and polycystic ovarian syndrome, breast cancer, endometriosis, leiomyoma and precocious puberty, estrogen dependent diseases |
| 02/03/2009 | US7485623 administering 4-hydroxy tamoxifen percutaneously to a patient having dense breast tissue; 4-hydroxy tamoxifen may be formulated in a hydroalcoholic gel or an alcoholic solution |
| 02/03/2009 | CA2409869C Novel solid body forms of mesoprogestin 11.beta.-[4e-(hydroxyiminomethyl)-phenyl]-17.alpha.-methoxymethyl-17.beta.-methoxy-estra-4,9-dien-3-one |
| 01/29/2009 | WO2009014150A1 Benzimidazole derivative |
| 01/29/2009 | WO2009014127A1 Composition for prevention or treatment of disease associated with the production of autoantibody |
| 01/29/2009 | WO2009013794A1 INSULIN SECRETION INDUCER, AND ACCELERATOR OF INCREASE IN PANCREATIC β-CELLS |
| 01/29/2009 | WO2009013354A1 ARYLMETHYLENE SUBSTITUTED N-ACYL-β-AMINO ALCOHOLS |
| 01/29/2009 | WO2009012650A1 Aryl pyrimidine derivatives, preparation methods and pharmaceutical uses thereof |
| 01/29/2009 | WO2009012647A1 Preparation methods of quinazoline derivatives and their pharmaceutical uses |
| 01/29/2009 | WO2008100769A3 Process for selective sulfation of aromatic hydroxyl groups |
| 01/29/2009 | US20090030080 Antagonists of the magnesium binding defect as therapeutic agents and methods for treatment of abnormal physiological states |
| 01/29/2009 | US20090029986 such as 1-{(S)-2-[(5-Bromo-pyrimidin-2-ylamino)-methyl]-piperidin-1-yl}-1-quinolin-2-yl-methanone, used as human orexin receptor antagonist, for the treatment of obesity and insomnia |
| 01/29/2009 | US20090029911 Liquid Human Growth Hormone Formulation Containing Polyethylene Glycol |
| 01/29/2009 | US20090028925 Novel Phosphinic Acid-Containing Thyromimetics |
| 01/29/2009 | CA2694222A1 Insulin secretion inducer, and accelerator for increasing the number of pancreatic .beta.-cells |
| 01/29/2009 | CA2694216A1 Benzimidazole derivative |
| 01/28/2009 | EP2018859A1 Arylmethylene substituted N-acyl-beta-amino alcohols |
| 01/28/2009 | EP2018384A2 Pyrimidine low molecular weight ligands for modulating hormone receptors |
| 01/28/2009 | EP2018170A2 Medication against breast cancer and related diseases |
| 01/28/2009 | CN101356185A Polymorphs of androgen receptor modulator - (N-3H-imidazo [4 , 5-B] pyridin-2-yl-methyl) -2-fluoro-4-methyl-3-oxo-4-aza-androst- l-en-17 . beta . -carboxamide |
| 01/28/2009 | CN101352475A Use of honeysuckle aqueous extract in preparing medicament for improving insulin resistance |
| 01/28/2009 | CN100455564C Histone de-acetylase inhibitor, preparation and application of pharmaceutical preparations of the same |
| 01/28/2009 | CN100455301C Therapeutical use of sophora flavescens or sophora subprostrated extracts |
| 01/27/2009 | US7482462 Immunosuppressants for treating skin disorders, acne, alopecia, estrogen- or androgen-dependent tumors, rheumatoid arthritis, type I and II diabetes, lupus erythematosus, multiple sclerosis, ulcerative colitis, Crohn's disease, psoriasis, contact dermatitis, graft versus host disease, eczema, asthma |
| 01/27/2009 | US7482024 highly dispersible mixture of drugs and dipeptides or tripeptides, in the form of liquids, aerosols or powders, administered by inhalation |
| 01/27/2009 | US7482013 Albumin fusion proteins |
| 01/27/2009 | CA2438168C Modulated release particles for aerosol delivery |
| 01/27/2009 | CA2416403C A medicinal aerosol formulation |
| 01/27/2009 | CA2395226C Devices for the delivery of drugs having antiprogestinic properties |
| 01/27/2009 | CA2380757C Pharmaceutical agent comprising a benzamide derivative as active ingredient |
| 01/27/2009 | CA2378803C Vitamin d3 analogs |
| 01/27/2009 | CA2377126C Thiazole and oxazole derivatives and their pharmaceutical use |
| 01/27/2009 | CA2354034C Compositions containing a peptide and polylactic-glycolic acid suitable for preparing subcutaneous implants with an extended release period |
| 01/22/2009 | US20090023739 Capase inhibitors and uses thereof |
| 01/22/2009 | US20090023659 Using cell surface adhesion proteins specific immunoglobulin to target therapeutics to tumorous; immunodiagnostics; immunotherapy |
| 01/22/2009 | US20090023634 Regulation of mineral and skeletal metabolism |
| 01/22/2009 | US20090022669 Compositions for protein delivery via the pulmonary route |
| 01/21/2009 | EP2015747A2 Use of n-aminoimidazole cytoprotective compounds for treating cell death and/or gsk-3 mediated diseases |
| 01/21/2009 | EP1924580B1 Non-steroidal compounds useful as glucocorticoid receptor modulators |
| 01/21/2009 | EP0850053B1 Erythrocytes loaded with s-nitrosothiol and uses therefor |
| 01/21/2009 | CN101348467A Substituted bicyclic derivatives for the treatment of abnormal cell growth |